Evidence map›Paper›PMID 42901891›Full record

ArticleNature communications2026

Learning chemical-induced gene expression perturbations with WAVE.

Tianhang Lv, Bojin Chen, Xiaoyue Dai, Meng Gao, Bingjie Zhu, Minjie Shen, Qin Zhu, Jie Liao, Xiaohui Fan

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Tianhang Lv *State Key Laboratory of Chinese Medicine Modernization, School of Pharmacy, Zhejiang University, Hangzhou, China.
Bojin Chen *State Key Laboratory of Chinese Medicine Modernization, School of Pharmacy, Zhejiang University, Hangzhou, China.
Xiaoyue DaiState Key Laboratory of Chinese Medicine Modernization, School of Pharmacy, Zhejiang University, Hangzhou, China.ORCID 0009-0001-5603-8281
Meng GaoState Key Laboratory of Chinese Medicine Modernization, School of Pharmacy, Zhejiang University, Hangzhou, China.
Bingjie ZhuState Key Laboratory of Chinese Medicine Modernization, School of Pharmacy, Zhejiang University, Hangzhou, China.
Minjie ShenState Key Laboratory of Chinese Medicine Modernization, School of Pharmacy, Zhejiang University, Hangzhou, China.
Qin ZhuHangzhou TCM Hospital Affiliated to Zhejiang Chinese Medical University, Zhejiang Chinese Medical University, Hangzhou, China.
Jie LiaoState Key Laboratory of Chinese Medicine Modernization, School of Pharmacy, Zhejiang University, Hangzhou, China. liaojie@zju.edu.cn.ORCID 0000-0002-6697-8998
Xiaohui FanState Key Laboratory of Chinese Medicine Modernization, School of Pharmacy, Zhejiang University, Hangzhou, China. fanxh@zju.edu.cn.ORCID 0000-0002-6336-3007

Funding

Ministry of Science and Technology of the People's Republic of China (Chinese Ministry of Science and Technology) New Generation Artificial Intelligence-National Science and Technology Major Project (2025ZD0122805)National Natural Science Foundation of China (National Science Foundation of China) 82522092National Natural Science Foundation of China (National Science Foundation of China) National Natural Science Foundation of China (82522092)
6 · The paper itself

Abstract

Chemical-induced transcriptional profiles facilitate systematic characterization of compound-driven perturbations, offering critical insights into mechanisms of action, especially for compounds with poorly defined molecular targets. However, experimentally profiling gene expression across all combinations of cell lines and compounds is impractical, limiting the large-scale application of comparative transcriptomics in drug screening. To address this, we developed a deep learning framework named WAVE (Wave Action-of-Drug with Variational Encoder), which predicts gene expression profiles from chemical structures and the basal states of cell lines and single cells. By effectively integrating drug molecular representations and cellular basal transcriptional profile using a β-variational autoencoder (β-VAE) framework, WAVE accurately predicts untested chemical-induced transcriptional profiles. Leveraging this integration of cellular insights and molecular characteristics, WAVE excels in drug discovery and drug repurposing based on in silico perturbation experiment. It's application in lung adenocarcinoma (LUAD) drug discovery showcased its potential to identify potentially effective compounds. Our results demonstrate the utility of WAVE for elucidating mechanisms of action for potential drugs and enabling large-scale drug screening.

Indexed as

Deep LearningDrug DiscoveryTranscriptomeAdenocarcinoma of LungAutoencoderCell Line, TumorDrug RepositioningGene Expression ProfilingHumansLung Neoplasms

Identifiers

PMID42901891
PMCPMC13683412

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.